Soleno Therapeutics, Inc. (SLNO)
52.95
+0.01
(+0.02%)
USD |
NASDAQ |
May 07, 16:00
52.95
0.00 (0.00%)
After-Hours: 20:00
Soleno Therapeutics Research and Development Expense (Annual) : 40.63M for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Neurocrine Biosciences, Inc. | 1.016B |
| Nektar Therapeutics | 117.07M |
| Forian, Inc. | 2.917M |
| Boston Scientific Corp. | 2.052B |
| Integer Holdings Corp. | 46.35M |